30 Going on 13

Show Floor, Moon Stage

October 10, 2023

Abby Miller Levy

Primetime Partners

Joe Betts-LaCroix

Retro Biosciences

Kristy Berry

Cenegenics

Melanie Goldey

Tally Health

Robert Hariri

Celularity Inc.

HTLH sessions summaries are sponsored by Abridge, the leader in real-time generative AI for clinical documentation. For a demo of the Abridge solution - used by thousands of clinicians everyday - see us at booth 5923. Video summaries are generated by a third party

In this panel discussion, the panelists, including leaders from companies like Primetime Partners, Tally Health, Retrobiosciences, Sinenigex, and Cellularity, discuss the topic of longevity and healthspan. They discuss the importance of studying and understanding the cellular mechanisms of aging, and highlight the potential advancements in longevity studies that could contribute to enhancing healthspan or lifespan. They also discuss the role of commercialization in moving these advancements from scientific research to usable products and treatments. They further delve into the importance of data analysis in understanding aging and healthspan, and the potential of using such data to drive behavioral changes for healthier living. Lastly, they discuss the challenges in integrating longevity studies and treatments into traditional healthcare systems and the importance of creating awareness about longevity.

The HLTH team is processing the video. Your summary will be ready soon. Check back later.